Allmed Medical Products Co.,Ltd
Shenzhen Stock ExchangeTotal Valuation
Allmed Medical Products Co.,Ltd carries a market capitalization of 5.96B, placing it among publicly traded companies globally. Its enterprise value stands at 5.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.96B |
| Enterprise Value | 5.23B |
Share Statistics
Allmed Medical Products Co.,Ltd currently has 633.27M shares outstanding.
| Shares Outstanding | 633.27M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Allmed Medical Products Co.,Ltd trades at a trailing price-to-earnings ratio of 14.27. The price-to-sales ratio is 1.59, and the price-to-book ratio stands at 1.92.
| PE Ratio | 14.27 |
| PS Ratio | 1.59 |
| PB Ratio | 1.92 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | 38.34 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Allmed Medical Products Co.,Ltd trades at an EV/EBITDA multiple of 10.38 and an EV/FCF ratio of 33.26. The EV/Sales ratio of 1.53 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.38 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.53 |
| EV / EBITDA | 10.38 |
| EV / EBIT | 10.38 |
| EV / FCF | 33.26 |
Financial Position
Allmed Medical Products Co.,Ltd maintains a current ratio of 2.08, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 14.55, indicating elevated leverage, while an interest coverage ratio of 27.07 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.08 |
| Quick Ratio | 0.79 |
| Debt / Equity | 14.55 |
| Debt / EBITDA | 1.04 |
| Interest Coverage | 27.07 |
Financial Efficiency
Allmed Medical Products Co.,Ltd posts a return on equity of 14.21 and a return on invested capital of 9.90.
| Return on Equity (ROE) | 14.21 |
| Return on Assets (ROA) | 7.55 |
| Return on Invested Capital (ROIC) | 9.90 |
| Return on Capital Employed (ROCE) | 11.52 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.03 |
Taxes
Over the trailing twelve months, Allmed Medical Products Co.,Ltd has paid 85.37M in income taxes, reflecting an effective tax rate of 18.15.
| Income Tax | 85.37M |
| Effective Tax Rate | 18.15 |
Stock Price Statistics
Allmed Medical Products Co.,Ltd's stock has gained approximately 7.54286% over the past 52 weeks. The 50-day moving average sits at 10.93, while the 200-day moving average is 11.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | 7.54286% |
| 50-Day Moving Average | 10.93 |
| 200-Day Moving Average | 11.23 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Allmed Medical Products Co.,Ltd generated 3.42B in revenue and converted that into 381.52M in net income, yielding earnings per share of 0.61. EBITDA reached 503.85M, while operating income came in at 503.85M.
| Revenue | 3.42B |
| Gross Profit | 998.39M |
| Operating Income | 503.85M |
| Pretax Income | 470.27M |
| Net Income | 381.52M |
| EBITDA | 503.85M |
| EBIT | 503.85M |
| Earnings Per Share (EPS) | 0.61 |
Balance Sheet
Allmed Medical Products Co.,Ltd holds 754.26M in cash and equivalents against 523.46M in total debt, resulting in a net debt position of -235.15M. Total book value stands at 2.84B, with working capital of 1.03B providing operational flexibility.
| Cash & Cash Equivalents | 754.26M |
| Total Debt | 523.46M |
| Net Debt | -235.15M |
| Equity (Book Value) | 2.84B |
| Book Value Per Share | 4.49 |
| Working Capital | 1.03B |
Cash Flow
After subtracting -142.04M in capital expenditures, free cash flow totaled -142.04M - equivalent to -0.22 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -142.04M |
| Free Cash Flow | -142.04M |
| FCF Per Share | -0.22 |
Margins
Allmed Medical Products Co.,Ltd operates with a gross margin of 29.18, reflecting its pricing power and cost economics. The operating margin of 14.73 and net profit margin of 11.15 provide insight into operational efficiency.
| Gross Margin | 29.18 |
| Operating Margin | 14.73 |
| Pretax Margin | 13.75 |
| Profit Margin | 11.15 |
| EBITDA Margin | 14.73 |
Dividends & Yields
The company's payout ratio of 14.99 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.09 |
| Dividend Yield | N/A |
| Payout Ratio | 14.99 |
| Shareholder Yield | 7.46 |
| FCF Yield | 2.61 |
Stock Splits
Allmed Medical Products Co.,Ltd's most recent stock split took place on June 5, 2020 with a 2:3 split ratio.
| Last Split Date | 6/5/2020 |
| Split Ratio | 2:3 |
Scores
Allmed Medical Products Co.,Ltd posts an Altman Z-Score of 4.26, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.26 |